发布求助
文献互助 智能选刊 最新文献

Biotechnology healthcare最新文献

筛选
英文 中文
A truer way to measure value of diagnostic tests. 一种更真实地衡量诊断试验价值的方法。
Biotechnology healthcare Pub Date : 2012-01-01
Bob Carlson
{"title":"A truer way to measure value of diagnostic tests.","authors":"Bob Carlson","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Helping payers track advanced diagnostics is a must in a health reform environment.</p>","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"9 4","pages":"34-5"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524740/pdf/bh0904034.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31146716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ASCO: The Science Was Grand, But What Will Payers Think? ASCO:科学是伟大的，但付款人会怎么想?
Biotechnology healthcare Pub Date : 2012-01-01
Michael D Dalzell
{"title":"ASCO: The Science Was Grand, But What Will Payers Think?","authors":"Michael D Dalzell","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"9 3","pages":"7-8"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474459/pdf/bh0903007.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30995271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Putting oncology patients at risk. 将肿瘤患者置于危险之中。
Biotechnology healthcare Pub Date : 2012-01-01
Bob Carlson
{"title":"Putting oncology patients at risk.","authors":"Bob Carlson","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Using genomic tests to personalize oncology treatment is a worthy endeavor. But when the rush to capitalize on biomedical research overcomes the rules of evidence, it's the patients who suffer.</p>","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"9 3","pages":"17-21"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474449/pdf/bh0903017.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30995274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Finding the Right Formula for Bundled Payments: Could reimbursements edge out biologics? 寻找捆绑支付的正确公式:报销能取代生物制剂吗?
Biotechnology healthcare Pub Date : 2012-01-01
John Carroll
{"title":"Finding the Right Formula for Bundled Payments: Could reimbursements edge out biologics?","authors":"John Carroll","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"9 1","pages":"8-9"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351891/pdf/bh0901008.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30627058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A conversation with cheryl larson: vice president, midwest business group on health. 与cheryl larson的对话:中西部商业集团健康副总裁。
Biotechnology healthcare Pub Date : 2012-01-01
Michael D Dalzell
{"title":"A conversation with cheryl larson: vice president, midwest business group on health.","authors":"Michael D Dalzell","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>By 2017, 40 percent of medical spend will be on biologics. It's time for employers to learn how to manage these drugs.</p>","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"9 1","pages":"16-9"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351892/pdf/bh0901016.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30627061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oncology costs must be reined in, say payers. 支付方表示，肿瘤治疗费用必须得到控制。
Biotechnology healthcare Pub Date : 2012-01-01
Katherine T Adams
{"title":"Oncology costs must be reined in, say payers.","authors":"Katherine T Adams","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"9 1","pages":"33"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351888/pdf/bh0901033.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30627066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MS Treatment Is on the Cusp of Something Big: On the Cusp of Something Big? 多发性硬化症的治疗正处于一个重要的转折点:在一个重要的转折点上?
Biotechnology healthcare Pub Date : 2012-01-01
Susan Worley
{"title":"MS Treatment Is on the Cusp of Something Big: On the Cusp of Something Big?","authors":"Susan Worley","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>For so long, multiple sclerosis has frustrated physicians and patients. With bold new treatments on the way, payers are thinking about tighter management. Formal treatment guidelines would help. Bio-markers could also sort out the 'right-drug, right-patient' conundrum.</p>","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"9 4","pages":"24-7"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524745/pdf/bh0904024.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31146714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PBM Consolidation: Better Pricing or Just Less Competition?: The growth of specialty pharmaceuticals, including biologics, is forcing payers and employers to look at cost-saving strategies for managing those drugs. How will they do it if only one large PBM rules the specialty pharmacy network? PBM整合:更好的定价还是更少的竞争?包括生物制剂在内的特种药品的增长，正迫使支付者和雇主考虑管理这些药品的成本节约策略。如果只有一家大型药品管理公司统治专业药房网络，他们将如何做到这一点?
Biotechnology healthcare Pub Date : 2012-01-01
Ed Silverman
{"title":"PBM Consolidation: Better Pricing or Just Less Competition?: The growth of specialty pharmaceuticals, including biologics, is forcing payers and employers to look at cost-saving strategies for managing those drugs. How will they do it if only one large PBM rules the specialty pharmacy network?","authors":"Ed Silverman","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>While the ramifications of Express Scripts' planned takeover of Medco are being debated, the use of pharmacy benefit managers is being questioned as cost savings decline and transparency issues hang high. And payers and employers still can't get rid of a \"bad taste in the mouth.\" So what does a mega PBM hope to accomplish?</p>","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"9 1","pages":"10-4"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351886/pdf/bh0901010.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30627060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Innovation flourishes at a time of benefit coverage uncertainty. 创新在利益覆盖不确定的时期蓬勃发展。
Biotechnology healthcare Pub Date : 2012-01-01
F Randy Vogenberg
{"title":"Innovation flourishes at a time of benefit coverage uncertainty.","authors":"F Randy Vogenberg","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"9 3","pages":"4"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474458/pdf/bh0903004.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30995269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biologics clinical trials, research, and FDA actions. 生物制剂临床试验、研究和FDA行动。
Biotechnology healthcare Pub Date : 2012-01-01
Michael D Dalzell
{"title":"Biologics clinical trials, research, and FDA actions.","authors":"Michael D Dalzell","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"9 4","pages":"4-5"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524742/pdf/bh0904004.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31146709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信